Log In
BCIQ
Print this Print this
 

LJPC-101

  Manage Alerts
Collapse Summary General Information
Company La Jolla Pharmaceutical Co.
DescriptionSubcutaneous formulation of GCS-100
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today